Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of 0.3% Hyaluronic Acid Eye Drops in Benign Essential Blepharospasm and Hemifacial Spasm
TCTR20220423002Phase 4Completed
- Sponsor
- Faculty of Medicine Ramathibodi Hospital, Mahidol University
- Start
- Apr 2020
- Countries
- 1
01
Overview
A Phase 4 trial of hyaluronic acid in idiopathic blepharospasm (BEB), hemifacial spasm (HFS), sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Started Apr 2020; status: completed.
02
Drugs
hyaluronic acid
03
Conditions
idiopathic blepharospasm (BEB)hemifacial spasm (HFS)
Beyond the preview
Go deeper on TCTR20220423002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220423002.